Terry Law
Family · St Petersburg, FLNPI 1063828903
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,755 of the $33,124 with a category attached, or 62.7%. Viiv Healthcare Company accounts for 82.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $11,796 and has fallen 97.3% since, to $317 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $86.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$27K
- Gilead$2K
- Johnson & Johnson$861
- Theratechnologies Inc.$722
- AbbVie$635
- Janssen Products, LP$299
- plus $1K from 10 others
What the payments were for
- Consulting fees$6202%
- Speaking & faculty fees$20,75563%
- Travel & lodging$2,0096%
- Food & beverage$9,49129%
- Education$2501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 160 | $27,474 |
| Gilead | 87 | $2,104 |
| Johnson & Johnson | 45 | $861 |
| Theratechnologies Inc. | 22 | $722 |
| AbbVie | 16 | $635 |
| Janssen Products, LP | 3 | $299 |
| Merck | 14 | $292 |
| Melinta Therapeutics, LLC | 11 | $240 |
| Janssen Scientific Affairs, LLC | 12 | $191 |
| Amarin Pharma, Inc. | 6 | $110 |
| Napo Pharmaceuticals Inc | 3 | $67 |
| EMD Serono, Inc. | 2 | $56 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Exact Sciences | 1 | $21 |
| GSK | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,124 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 53 | $214,768 |
| RukobiaFostemsavir Tromethamine | 12 | $107,337 |
| TivicayDolutegravir Sodium | 19 | $53,066 |
| PrezcobixDarunavir/Cobicistat | 16 | $39,166 |
| DovatoDolutegravir Sodium/Lamivudine | 13 | $37,826 |
| Westab PlusPnv,calcium 72/Iron/Folic Acid | 11 | $190 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $2,104 | $214,76853 claims |
| Viiv Healthcare CompanyRukobia, Tivicay, Dovato | $27,474 | $198,23044 claims |
| Johnson & JohnsonPrezcobix | $861 | $39,16616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in St Petersburg
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.